Barclays
PDSB icon

Barclays’s PDS Biotechnology PDSB Stock Holding History

Barclays’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Sell
2
-580
-100% -$329 ﹤0.01% 5316
2026
Q2 		$513 Buy
+582
New +$618 ﹤0.01% 5005
2024
Q3 		– Sell
-1
Closed -$3 – 5430
2024
Q2 		$3 Sell
1
-19,765
-100% -$63.2K ﹤0.01% 4795
2024
Q1 		$78.3K Sell
19,766
-18,636
-49% -$96K ﹤0.01% 4516
2023
Q4 		$191K Buy
38,402
+33,488
+681% +$166K ﹤0.01% 4439
2023
Q3 		$24.8K Sell
4,914
-657
-12% -$3.6K ﹤0.01% 4125
2023
Q2 		$28K Sell
5,571
-33,684
-86% -$221K ﹤0.01% 4056
2023
Q1 		$241K Buy
+39,255
New +$321K ﹤0.01% 3683
2021
Q4 		– Sell
-14,728
Closed -$219K – 4578
2021
Q3 		$219K Buy
+14,728
New +$184K ﹤0.01% 3573
2020
Q3 		– Sell
-37
Closed – – 5482
2020
Q2 		$0 Buy
+37
New +$41 ﹤0.01% 6088
2019
Q4 		– Sell
-1
Closed – – 6699
2019
Q3 		$0 Buy
+1
New +$6 ﹤0.01% 7024
2018
Q2 		– Sell
-219
Closed -$5K – 7203
2018
Q1 		$5K Buy
219
+57
+35% +$15.3K ﹤0.01% 6793
2017
Q4 		$31K Buy
162
+139
+604% +$28K ﹤0.01% 6044
2017
Q3 		$5K Buy
23
+7
+44% +$1.45K ﹤0.01% 6421
2017
Q2 		$3K Buy
16
+12
+300% +$2.36K ﹤0.01% 6354
2017
Q1 		$1K Sell
4
-16
-80% -$3.17K ﹤0.01% 6609
2016
Q4 		$5K Buy
20
+15
+300% +$3.41K ﹤0.01% 6138
2016
Q3 		$1K Sell
5
-194
-97% -$38.4K ﹤0.01% 6417
2016
Q2 		$40K Buy
+199
New +$35.2K ﹤0.01% 4954
2016
Q1 		– Sell
-6
Closed -$1K – 6370
2015
Q4 		$1K Buy
+6
New +$1.93K ﹤0.01% 5837

Other funds holding PDSB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Inspirion Wealth Advisors
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Provenance Wealth Advisors
Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Tempus Wealth Planning
Tempus Wealth Planning Irvine, California $522M AUM 17.46% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Barclays's PDSB Position: Q3 2026 in Review

Barclays reduced its PDS Biotechnology (PDSB) stake by 100% in Q3 2026, selling an estimated $329 and leaving 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

Barclays first reported a position in PDSB in Q4 2015 and has held it in 20 quarters since. The position peaked at $241K in Q1 2023. 24 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Barclays held 2 shares of PDS Biotechnology worth $2 as of Q3 2026.
  • Barclays sold 580 PDS Biotechnology shares in Q3 2026, an estimated $329.
  • PDS Biotechnology made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5316 holding.
  • Barclays first reported a position in PDS Biotechnology in Q4 2015 and has held it in 20 quarters since.
  • Barclays's PDS Biotechnology position peaked at $241K in Q1 2023.
  • 24 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.